(Alliance News) - London's FTSE 100 underperformed European peers, but headed into Wednesday afternoon just about in the green as a US inflation reading looms. Read More
(Alliance News) - European stocks slid on Tuesday with a double-digit fall in BMW knocking Frankfurt and declines for index heavyweights AstraZeneca, BP and Shell weighing on London. Read More
(Alliance News) - London's FTSE 100 traded lower on Tuesday, underperforming European peers, as index heavyweights in pharmaceuticals, mining, and oil were in the red. Read More
(Alliance News) - AstraZeneca PLC shares weakened on Tuesday morning, after tepid results from a lung cancer drug trial left investors fretting about regulatory approval chances. Read More
(Alliance News) - London's FTSE 100 started the day on the back foot, returning some of its advance from the start of the week, ahead of US data and a presidential debate across the Atlantic. Read More
(Alliance News) - Stocks faded into the close on Thursday to end in the red weighed by a drop in index heavyweight AstraZeneca on a day of mixed news for blue-chips. Read More
(Alliance News) - Several employees of multinational pharmaceutical firm AstraZeneca PLC are under investigation in China, the firm told AFP Thursday, after a report said they were being questioned about potentially illegal data collection and drug imports. Read More
(Alliance News) - AstraZeneca PLC on Tuesday announced that China's National Medical Products Association has approved benralizumab to treat patients aged 12 and older with severe eosinophilic asthma. Read More
(Alliance News) - Stocks in London are called to open lower on Tuesday, as investors look ahead to a key inflation reading from the eurozone. Read More
(Alliance News) - Daiichi Sankyo Co Ltd on Monday announced positive updates for Enhertu, with the cancer drug receiving support from US and European regulators. Read More
(Alliance News) - AstraZeneca PLC on Friday said Imfinzi has been approved in the US for the treatment of resectable non-small cell lung cancer before and after surgery. Read More
(Alliance News) - AstraZeneca PLC on Thursday said Imfinzi has been granted priority review and breakthrough therapy designation for patients with limited-stage small cell lung cancer in the US. Read More
(Alliance News) - Stock prices in London opened a mixed bag on Thursday, with the FTSE 100 in the green but others trailing behind, after data showed no monthly growth in the UK economy. Read More
(Alliance News) - Stock prices in London were higher at midday on Wednesday, as the market remained optimistic following a UK CPI print in the morning, and ahead of one from the US later in the afternoon. Read More
(Alliance News) - Stock prices in London started the day in the green, even after local economic data showed an acceleration in UK consumer price inflation for the first time since December. Read More
(Alliance News) - Stock prices in London were in the red at midday, as investor sentiment turned ahead of the next inflationary print from the US this afternoon. Read More
(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Tuesday said their joint product Enhertu has received a third approval in China. Read More